IMMUNITAS THERAPEUTICS

immunitas-therapeutics-logo

Immunitas is unlocking human immunology using novel single cell analyses to develop targeted therapeutics for patients with challenging, complex cancers. Translating findings from laboratory research to meaningful clinical advances in humans is a longstanding challenge in the oncology field. Immunitas was founded to directly address this problem and unlock a variety of novel drug targets based on discovery rooted in human biology. They are pursuing this goal with a team of pioneers in these are... as across their scientific founders, management, and investors. At Immunitas, they employ a single cell sequencing platform to dissect the biology of immune cells in human tumors. Their focus on human samples allows us to start with and stay closer to the most relevant and translatable biology for patients and accelerates the pace of their research. They are identifying novel, exciting oncology targets and, importantly, developing key biomarkers to guide the selection of patients who may benefit from their new drugs. They are leveraging expertise in antibody discovery and engineering to create powerful therapies that modulate these targets, and are currently advancing a number of programs toward early human studies.

#SimilarOrganizations #People #Financial #Event #Website #More

IMMUNITAS THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Life Science Therapeutics

Founded:
2019-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.immunitastx.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
97 M USD

Technology used in webpage:
Euro Microsoft Azure DNS Squarespace Hosted Mimecast


Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

aub-logo

AuB

AuB is an intestinal microflora analysis that contributes to the athlete's performance improvement and human health maintenance.

autobahn-therapeutics-logo

Autobahn Therapeutics

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

hive-logo

Hive

Hive Biosystems helps pharmaceutical companies streamline genetics-driven drug discovery by rapidly generating transgenic animals.

inso-biosciences-logo

Inso Biosciences

Inso Bio is a Cornell University-based early-stage biotech company that develops platform technology for biological sample processing.

kingdom-supercultures-logo

Kingdom Supercultures

Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits.

st-teresa-medical-logo

St. Teresa Medical

St. Teresa Medical is a medical applications developing company commercializing a hemostatic technology platform called FASTCLOT.

tagbio-logo

Tag.bio

Tag.bio has developed a novel data science platform that allows domain experts to quickly find insights in data.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

xinthera-logo

XinThera

XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.


Current Advisors List

brian-halak_image

Brian Halak Board Member @ Immunitas Therapeutics
Board_member

lucio-iannone_image

Lucio Iannone Board Member @ Immunitas Therapeutics
Board_member

laura-brass_image

Laura Brass Board Member @ Immunitas Therapeutics
Board_member

christoph-westphal_image

Christoph Westphal Board Member @ Immunitas Therapeutics
Board_member

juergen-eckhardt_image

Juergen Eckhardt Board Member @ Immunitas Therapeutics
Board_member

jurg-eckhardt_image

Jurg Eckhardt Board Member @ Immunitas Therapeutics
Board_member
2019-10-01

geeta-vemuri_image

Geeta Vemuri Board Member @ Immunitas Therapeutics
Board_member

k-dane-wittrup_image

K. Dane Wittrup Member, Scientific Advisory Board @ Immunitas Therapeutics
Advisor
2019-06-01

Current Employees Featured

k-dane-wittrup_image

K. Dane Wittrup
K. Dane Wittrup Co-founder @ Immunitas Therapeutics
Co-founder
2019-06-01

kai-wucherpfennig_image

Kai Wucherpfennig
Kai Wucherpfennig Scientific Co-Founder @ Immunitas Therapeutics
Scientific Co-Founder

mario-suva_image

Mario Suva
Mario Suva Scientific Co-Founder @ Immunitas Therapeutics
Scientific Co-Founder

lynette-herscha_image

Lynette Herscha
Lynette Herscha Chief Operating Officer @ Immunitas Therapeutics
Chief Operating Officer
2022-07-01

not_available_image

Seng-Lai "Thomas" Tan
Seng-Lai "Thomas" Tan Chief Scientific Officer @ Immunitas Therapeutics
Chief Scientific Officer
2021-09-01

amanda-wagner_image

Amanda Wagner
Amanda Wagner Chief Executive Officer @ Immunitas Therapeutics
Chief Executive Officer
2021-11-01

Founder


amanda-wagner_image

Amanda Wagner

k-dane-wittrup_image

K. Dane Wittrup

kai-wucherpfennig_image

Kai Wucherpfennig

lea-hachigian_image

Lea Hachigian

mario-suva_image

Mario Suva

Investors List

merckventures_image

M Ventures

M Ventures investment in Series B - Immunitas Therapeutics

evotec-inc_image

Evotec

Evotec investment in Series B - Immunitas Therapeutics

120-capital-management_image

120 Capital Management

120 Capital Management investment in Series B - Immunitas Therapeutics

ns-investment_image

NS Investment

NS Investment investment in Series B - Immunitas Therapeutics

brightedge-fund_image

BrightEdge Fund

BrightEdge Fund investment in Series B - Immunitas Therapeutics

leaps-by-bayer_image

Leaps by Bayer

Leaps by Bayer investment in Series B - Immunitas Therapeutics

medical-excellence-capital_image

Medical Excellence Capital

Medical Excellence Capital investment in Series B - Immunitas Therapeutics

longwood-founders-fund_image

Longwood Fund

Longwood Fund investment in Series B - Immunitas Therapeutics

ono-venture-investment_image

Ono Venture Investment

Ono Venture Investment investment in Series B - Immunitas Therapeutics

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series B - Immunitas Therapeutics

Official Site Inspections

http://www.immunitastx.com Semrush global rank: 2.96 M Semrush visits lastest month: 5.5 K

  • Host name: 198.185.159.145
  • IP address: 198.185.159.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Immunitas Therapeutics" on Search Engine